loading
Precedente Chiudi:
$18.22
Aprire:
$17.78
Volume 24 ore:
522.45K
Relative Volume:
0.13
Capitalizzazione di mercato:
$13.30B
Reddito:
$220.00K
Utile/perdita netta:
$-746.08M
Rapporto P/E:
-17.76
EPS:
-1.0074
Flusso di cassa netto:
$-211.81M
1 W Prestazione:
-6.76%
1M Prestazione:
-16.33%
6M Prestazione:
-35.73%
1 anno Prestazione:
-10.17%
Intervallo 1D:
Value
$17.75
$18.13
Intervallo di 1 settimana:
Value
$17.75
$19.34
Portata 52W:
Value
$15.55
$36.91

Summit Therapeutics Inc Stock (SMMT) Company Profile

Name
Nome
Summit Therapeutics Inc
Name
Telefono
305-203-2034
Name
Indirizzo
601 BRICKELL KEY DRIVE, MIAMI
Name
Dipendente
159
Name
Cinguettio
@summitplc
Name
Prossima data di guadagno
2025-10-20
Name
Ultimi documenti SEC
Name
SMMT's Discussions on Twitter

Confronta SMMT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SMMT
Summit Therapeutics Inc
17.90 13.56B 220.00K -746.08M -211.81M -1.0074
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.82 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
636.01 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
428.17 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
841.94 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
185.52 39.72B 447.02M -1.18B -868.57M -6.1812

Summit Therapeutics Inc Stock (SMMT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-17 Iniziato Barclays Underweight
2025-09-04 Iniziato Guggenheim Buy
2025-08-19 Iniziato Piper Sandler Neutral
2025-07-01 Iniziato UBS Buy
2025-06-11 Iniziato Leerink Partners Underperform
2025-03-26 Aggiornamento Citigroup Neutral → Buy
2025-03-21 Iniziato Cantor Fitzgerald Overweight
2025-03-12 Iniziato Evercore ISI Outperform
2025-02-28 Iniziato Goldman Buy
2025-01-08 Iniziato Truist Buy
2024-12-11 Iniziato Wells Fargo Overweight
2024-12-06 Iniziato Jefferies Buy
2024-11-04 Iniziato JMP Securities Mkt Outperform
2024-09-27 Downgrade Citigroup Buy → Neutral
2024-08-12 Iniziato H.C. Wainwright Buy
2024-05-07 Iniziato Citigroup Buy
2024-03-26 Iniziato Stifel Buy
2018-06-28 Downgrade Janney Buy → Neutral
2018-05-02 Iniziato Janney Buy
2018-04-12 Reiterato Needham Buy
2018-02-13 Iniziato BTIG Research Buy
2018-01-04 Iniziato SunTrust Buy
2017-12-01 Ripresa H.C. Wainwright Buy
2016-11-16 Reiterato RBC Capital Mkts Outperform
2016-10-05 Reiterato Needham Buy
2016-09-16 Iniziato H.C. Wainwright Buy
2015-03-30 Iniziato Needham Buy
2015-03-30 Iniziato Oppenheimer Outperform
Mostra tutto

Summit Therapeutics Inc Borsa (SMMT) Ultime notizie

pulisher
07:00 AM

Summit Therapeutics to Present at Upcoming Investor Conferences - FinancialContent

07:00 AM
pulisher
04:18 AM

What institutional flow reveals about Summit Therapeutics Inc.Swing Trade & Smart Investment Allocation Tips - newser.com

04:18 AM
pulisher
Nov 03, 2025

Summit Therapeutics (SMMT) Is Down 6.4% After $513M Shelf Filing and Ivonescimab Clinical Updates—Has The Bull Case Changed? - Yahoo Finance

Nov 03, 2025
pulisher
Nov 03, 2025

A Look at Summit Therapeutics (SMMT) Valuation Following Positive HARMONi Trial Results and Regulatory Progress - Yahoo Finance

Nov 03, 2025
pulisher
Nov 03, 2025

Is Summit Therapeutics Inc. showing signs of accumulation2025 Geopolitical Influence & Stepwise Swing Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What MACD and RSI say about Summit Therapeutics Inc.2025 Short Interest & Accurate Technical Buy Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Summit Therapeutics Inc. hit a new high this monthJuly 2025 Trends & Community Consensus Picks - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Is Summit Therapeutics Inc. stock reversal real or fakeMarket Trend Report & Weekly Market Pulse Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

1 Monster Stock in the Making to Buy and Hold - AOL.com

Nov 02, 2025
pulisher
Nov 02, 2025

Summit Therapeutics PLC (NASDAQ:SMMT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

News impact scoring models applied to Summit Therapeutics Inc.Portfolio Value Report & Weekly Hot Stock Watchlists - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Insiders Are Snapping Up These 2 Stocks — and Analysts Like What They See - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Should you hold or exit Summit Therapeutics Inc. now2025 Volume Leaders & High Conviction Investment Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Overall Survival Data from HARMONi-A, Featuring Ivonescimab in Combination with Chemotherapy vs. Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC in China, to be Showcased at SITC 2025 - Business Wire

Oct 31, 2025
pulisher
Oct 31, 2025

Applying sector rotation models to Summit Therapeutics Inc.2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Summit Therapeutics (SMMT) Aims for FDA Nod for Ivonescimab in N - GuruFocus

Oct 31, 2025
pulisher
Oct 30, 2025

Jefferies Cuts Summit Therapeutics (SMMT) Price Target, Keeps Buy Rating - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

Summit Therapeutics (SMMT) Releases Financial Results and Updates on Operational Progress for Q3 2025 - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

Summit Therapeutics Inc.Common Stock (NQ: SMMT - FinancialContent

Oct 30, 2025
pulisher
Oct 30, 2025

13 Stocks to Buy with Exponential Growth Heading into 2026 - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

10 Stocks Under $20 to Buy According to Analysts - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

Summit Therapeutics (SMMT) files for 26.68M share offering by selling stockholders - StreetInsider

Oct 30, 2025
pulisher
Oct 29, 2025

Why Wall Street Is Backing These 3 Comeback Stocks - Investing.com

Oct 29, 2025
pulisher
Oct 29, 2025

Patterns Watch: Is Summit Therapeutics Inc. stock a safe haven asset2025 Volume Leaders & Weekly High Return Stock Forecasts - fcp.pa.gov.br

Oct 29, 2025
pulisher
Oct 28, 2025

Co-CEO & Executive Chairman of Summit Therapeutics Picks Up 2.5% More Stock - simplywall.st

Oct 28, 2025
pulisher
Oct 28, 2025

Co-CEO & Executive Chairman of Summit Therapeutics Robert Duggan Buys 2.5% More Shares - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Insider Spends US$262m Buying More Shares In Summit Therapeutics - 富途牛牛

Oct 28, 2025
pulisher
Oct 28, 2025

Can Summit Therapeutics Inc. stock outperform in 2025 bull marketEarnings Overview Summary & Real-Time Volume Analysis Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Analyzing Summit Therapeutics Inc. with risk reward ratio charts2025 Price Targets & High Return Stock Watch Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Allianz Asset Management GmbH Decreases Stock Holdings in Summit Therapeutics PLC $SMMT - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

What margin trends mean for Summit Therapeutics Inc. stock2025 Top Decliners & Fast Exit/Entry Strategy Plans - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

Summit Therapeutics proves InvestingPro’s Fair Value accuracy with 40% return By Investing.com - Investing.com South Africa

Oct 27, 2025

Summit Therapeutics Inc Azioni (SMMT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.84
price up icon 1.52%
$29.02
price up icon 1.11%
$103.05
price up icon 1.34%
$104.02
price up icon 0.06%
biotechnology ONC
$312.19
price up icon 0.10%
$185.72
price down icon 0.10%
Capitalizzazione:     |  Volume (24 ore):